Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Glycar, Inc. — Predicate Candidate Screening

5 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

176 daysmedian FDA review time
430 days90th percentile
5clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K963368GLYCARTISSUE REPAIR PATCH FAMILY OF PRODUCTS; GLYCAR VASCULAGlycar, Inc.1997-10-314300
K963967GLYCAR PERICARDIAL PATCHGlycar, Inc.1997-10-313942
K963175GLYCAR TISSUE REPAIR PATCH, BIO-PATCH, URO-SLINGGlycar, Inc.1996-09-23400
K954665GLYCAR STAPLE STRIPSGlycar, Inc.1996-02-141270
K942911GLYCAR TISSUE REPAIR PATCHGlycar, Inc.1994-12-141760

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda